Web24 de set. de 2024 · September 24, 2024, 8:00 AM · 4 min read. NEWTOWN, Pa., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on ... Web10 de abr. de 2024 · Financial Performance. In 2024, ONTX's revenue was $226,000, a change of 0.00% compared to the previous year's $226,000. Losses were -$18.96 million, 17.3% more than in 2024. Financial Statements.
Onconova Therapeutics, Inc. Announces Pricing of $21
Web13 de abr. de 2024 · ONTX Onconova Therapeutics, Inc.Stock Price & Overview. $0.80 … WebView today's ONTX stock price, trade commission-free, and discuss ONTX stock updates with the investor community. ... An affiliate of Public may be “testing the waters” and considering making an offering of securities under Tier 2 of Regulation A. No money or other consideration is being solicited and, if sent in response, ... howard norman liverpool
Onconova
WebBiotech stock updates 12/18 PRTK BARDA contract +78% AH EPZM +ve AdCom +10% +NDA filing NERV fail -29% AH SYRS collaboration with GBT +16% AXSM offering... Pular para Seções desta Página Web5 de abr. de 2024 · Onconova Therapeutics, Inc. (ONTX) projections and forecasts Consensus estimates provided by 1 financial analysts predict the company will bring in an average of $60Million in revenue for the current quarter. 1 analysts expect Onconova Therapeutics, Inc. to make $60Million in revenue for the quarter ending June 01, 2024. Web7 de jan. de 2024 · The gross proceeds to Onconova from this offering are expected to … howard norman facebook